α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model

Vaccine

Volumn 29, Issue 51, 2011, Pages 9529-9537

  Jenikova, Gabriela ^a   Hruz, Petr ^a   Andersson, Mattias K ^a   Tejman Yarden, Noa ^a   Ferreira, Patricia C D ^a   Andersen, Yolanda S ^a   Davids, Barbara J ^a   Gillin, Frances D ^a   Svärd, Staffan G ^b   Curtiss, Roy ^c   Eckmann, Lars ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Animal models; Giardiasis; Live oral vaccines

Indexed keywords

ALPHA 1 GIARDIN VACCINE; ALPHA ENOLASE; ANTIGEN; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; LIVE VACCINE; ORNITHINE CARBAMOYLTRANSFERASE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CROSS REACTION; DISEASE MODEL; DRUG DEVELOPMENT; FEMALE; GIARDIA LAMBLIA; GIARDIASIS; IMMUNIZATION; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHOLERA TOXIN; CYTOSKELETAL PROTEINS; GIARDIA LAMBLIA; GIARDIASIS; MICE; MICE, INBRED BALB C; ORNITHINE CARBAMOYLTRANSFERASE; PHOSPHOPYRUVATE HYDRATASE; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SALMONELLA TYPHIMURIUM; VACCINES, SYNTHETIC;

EID: 81955164754     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.126     Document Type: Article

References (60)

1. Karanis P., Kourenti C., Smith H. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J Water Health 2007, 5:1-38.
2. Majewska A.C. Successful experimental infections of a human volunteer and Mongolian gerbils with Giardia of animal origin. Trans R Soc Trop Med Hyg 1994, 88:360-362.
3. Nash T.E., Herrington D.A., Losonsky G.A., Levine M.M. Experimental human infections with Giardia lamblia. J Infect Dis 1987, 156:974-984.
4. Flanagan P.A. Giardia-diagnosis clinical course and epidemiology. A review. Epidemiol Infect 1992, 109:1-22.
5. Buret A.G. Pathophysiology of enteric infections with Giardia duodenalius. Parasite 2008, 15:261-265.
6. Olson M.E., Ceri H., Morck D.W. Giardia vaccination. Parasitol Today 2000, 16:213-217.
7. Uehlinger F.D., O'Handley R.M., Greenwood S.J., Guselle N.J., Gabor L.J., Van Velsen C.M., et al. Efficacy of vaccination in preventing giardiasis in calves. Vet Parasitol 2007, 146:182-188.
8. Abdul-Wahid A., Faubert G. Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis. Int J Parasitol 2008, 38:691-703.
9. Larocque R., Nakagaki K., Lee P., Abdul-Wahid A., Faubert G.M. Oral immunization of BALB/c mice with Giardia duodenalis recombinant cyst wall protein inhibits shedding of cysts. Infect Immun 2003, 71:5662-5669.
10. Lee P., Abdul-Wahid A., Faubert G.M. Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii. Microbes Infect 2009, 11:20-28.
11. Abdul-Wahid A., Faubert G. Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle. Vaccine 2007, 25:8372-8383.
12. Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev 2000, 13:35-54.
13. Nash T.E. Surface antigenic variation in Giardia lamblia. Mol Microbiol 2002, 45:585-590.
14. Singer S.M., Elmendorf H.G., Conrad J.T., Nash T.E. Biological selection of variant-specific surface proteins in Giardia lamblia. J Infect Dis 2001, 183:119-124.
15. Bienz M., Siles-Lucas M., Wittwer P., Muller N. vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro. Infect Immun 2001, 69:5278-5285.
16. Prucca C.G., Slavin I., Quiroga R., Elias E.V., Rivero F.D., Saura A., et al. Antigenic variation in Giardia lamblia is regulated by RNA interference. Nature 2008, 456:750-754.
17. Rivero F.D., Saura A., Prucca C.G., Carranza P.G., Torri A., Lujan H.D. Disruption of antigenic variation is crucial for effective parasite vaccine. Nat Med 2010, 16:551-557.
18. Morrison H.G., McArthur A.G., Gillin F.D., Aley S.B., Adam R.D., Olsen G.J., et al. Genomic minimalism in the early diverging intestinal parasite Giardia lamblia. Science 2007, 317:1921-1926.
19. Franzen O., Jerlstrom-Hultqvist J., Castro E., Sherwood E., Ankarklev J., Reiner D.S., et al. Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species?. PLoS Pathog 2009, 5:e1000560.
20. Palm J.E., Weiland M.E., Griffiths W.J., Ljungstrom I., Svard S.G. Identification of immunoreactive proteins during acute human giardiasis. J Infect Dis 2003, 187:1849-1859.
21. Tellez A., Palm D., Weiland M., Aleman J., Winiecka-Krusnell J., Linder E., et al. Secretory antibodies against Giardia intestinalis in lactating Nicaraguan women. Parasite Immunol 2005, 27:163-169.
22. Davids B.J., Palm J.E., Housley M.P., Smith J.R., Andersen Y.S., Martin M.G., et al. Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite Giardia. J Immunol 2006, 177:6281-6290.
23. Curtiss R. Bacterial infectious disease control by vaccine development. J Clin Invest 2002, 110:1061-1066.
24. Ebensen T., Guzman C.A. Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. Hum Vaccin 2008, 4:13-22.
25. Perrie Y., Mohammed A.R., Kirby D.J., McNeil S.E., Bramwell V.W. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 2008, 364:272-280.
26. Cheminay C., Hensel M. Rational design of Salmonella recombinant vaccines. Int J Med Microbiol 2008, 298:87-98.
27. Stager S., Gottstein B., Muller N. Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain. Int J Parasitol 1997, 27:965-971.
28. Byrd L.G., Conrad J.T., Nash T.E. Giardia lamblia infections in adult mice. Infect Immun 1994, 62:3583-3585.
29. Boreham P.F., Phillips R.E., Shepherd R.W. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother 1984, 14:449-461.
30. Capon A.G., Upcroft J.A., Boreham P.F., Cottis L.E., Bundesen P.G. Similarities of Giardia antigens derived from human and animal sources. Int J Parasitol 1989, 19:91-98.
31. Li Y., Wang S., Xin W., Scarpellini G., Shi Z., Gunn B., et al. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun 2008, 76:5238-5246.
32. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat Biotechnol 1988, 6:693-697.
33. Kang H.Y., Srinivasan J., Curtiss R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine. Infect Immun 2002, 70:1739-1749.
34. Hitchcock P.J., Brown T.M. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983, 154:269-277.
35. Ringqvist E., Palm J.E., Skarin H., Hehl A.B., Weiland M., Davids B.J., et al. Release of metabolic enzymes by Giardia in response to interaction with intestinal epithelial cells. Mol Biochem Parasitol 2008, 159:85-91.
36. Raghavan S., Ostberg A.K., Flach C.F., Ekman A., Blomquist M., Czerkinsky C., et al. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun 2010, 78:4251-4260.
37. von Allmen N., Bienz M., Hemphill A., Muller N. Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83-H7 are associated with an antigenic reset of the parasite. Infect Immun 2004, 72:4763-4771.
38. Rahn K., De Grandis S.A., Clarke R.C., McEwen S.A., Galan J.E., Ginocchio C., et al. Amplification of an invA gene sequence of Salmonella typhimurium by polymerase chain reaction as a specific method of detection of Salmonella. Mol Cell Probes 1992, 6:271-279.
39. Monis P.T., Andrews R.H., Mayrhofer G., Ey P.L. Molecular systematics of the parasitic protozoan Giardia intestinalis. Mol Biol Evol 1999, 16:1135-1144.
40. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
41. Curtiss R., Xin W., Li Y., Kong W., Wanda S.Y., Gunn B., et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol 2010, 30:255-270.
42. Wang S., Li Y., Scarpellini G., Kong W., Shi H., Baek C.H., et al. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect Immun 2010, 78:3969-3980.
43. Singer S.M., Nash T.E. T-cell-dependent control of acute Giardia lamblia infections in mice. Infect Immun 2000, 68:170-175.
44. Vinayak V.K., Kum K., Khanna R., Khuller M. Systemic-oral immunization with 56 kDa molecule of Giardia lamblia affords protection in experimental mice. Vaccine 1992, 10:21-27.
45. Langford T.D., Housley M.P., Boes M., Chen J., Kagnoff M.F., Gillin F.D., et al. Central importance of immunoglobulin A in host defense against Giardia spp. Infect Immun 2002, 70:11-18.
46. Sulaiman I.M., Fayer R., Bern C., Gilman R.H., Trout J.M., Schantz P.M., et al. Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis 2003, 9:1444-1452.
47. Buret A.G. Mechanisms of epithelial dysfunction in giardiasis. Gut 2007, 56:316-317.
48. Gaucher D., Chadee K. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine. Parasite Immunol 2003, 25:55-58.
49. Weiland M.E., McArthur A.G., Morrison H.G., Sogin M.L., Svard S.G. Annexin-like alpha giardins: a new cytoskeletal gene family in Giardia lamblia. Int J Parasitol 2005, 35:617-626.
50. Peattie D.A., Alonso R.A., Hein A., Caulfield J.P. Ultrastructural localization of giardins to the edges of disk microribbons of Giarida lamblia and the nucleotide and deduced protein sequence of alpha giardin. J Cell Biol 1989, 109:2323-2335.
51. Jenkins M.C., O'Brien C.N., Murphy C., Schwarz R., Miska K., Rosenthal B., et al. Antibodies to the ventral disc protein delta-giardin prevent in vitro binding of Giardia lamblia trophozoites. J Parasitol 2009, 95:895-899.
52. Weiland M.E., Palm J.E., Griffiths W.J., McCaffery J.M., Svard S.G. Characterisation of alpha-1 giardin: an immunodominant Giardia lamblia annexin with glycosaminoglycan-binding activity. Int J Parasitol 2003, 33:1341-1351.
53. Veiga-Malta I., Duarte M., Dinis M., Tavares D., Videira A., Ferreira P. Enolase from Streptococcus sobrinus is an immunosuppressive protein. Cell Microbiol 2004, 6:79-88.
54. Pancholi V., Fischetti V.A. alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 1998, 273:14503-14515.
55. Andersen Y.S., Gillin F.D., Eckmann L. Adaptive immunity-dependent intestinal hypermotility contributes to host defense against Giardia spp. Infect Immun 2006, 74:2473-2476.
56. Montagnoli C., Sandini S., Bacci A., Romani L., La Valle R. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol 2004, 42:319-324.
57. Xin W., Wanda S.Y., Li Y., Wang S., Mo H., Curtiss R. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun 2008, 76:3241-3254.
58. Eko F.O., He Q., Brown T., McMillan L., Ifere G.O., Ananaba G.A., et al. A novel recombinant multisubunit vaccine against Chlamydia. J Immunol 2004, 173:3375-3382.
59. Kong W., Wanda S.Y., Zhang X., Bollen W., Tinge S.A., Roland K.L., et al. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci USA 2008, 105:9361-9366.
60. Yang X., Hinnebusch B.J., Trunkle T., Bosio C.M., Suo Z., Tighe M., et al. Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 2007, 178:1059-1067.